Literature DB >> 14746413

Medical comorbidity in black and white patients with Alzheimer's disease.

Edward Zamrini1, Jo Ann Parrish, Dee Parsons, Lindy E Harrell.   

Abstract

BACKGROUND: Little is known about co-medical illnesses in black and white patients with probable Alzheimer's disease (AD).
METHODS: To address this question, we used two methods. In the first (Group I), black and white probable AD patients were matched on age at presentation to the clinic, age of onset of AD, duration of illness, and Mini-Mental State Examination scores; then, a variety of co-medical illnesses were compared between blacks and whites. In Group II, whites were randomly matched to blacks on the variables listed above.
RESULTS: In Group I, blacks were found to have a higher rate of hypertension than whites, whereas whites had a higher incidence of atrial fibrillation and cancer than blacks. In Group II, age at presentation to the clinic was found to be shorter for men than for women; duration of illness was shorter for black men than for white men, white women, and black women; and Mini-Mental State Examination scores were lower in blacks than whites. As in Group I, blacks were found to have a higher rate of hypertension, whereas whites had higher rates of atrial fibrillation, cancer, coronary artery disease, high cholesterol, and gastrointestinal disease.
CONCLUSION: In both groups, black patients with probable AD had a higher rate of hypertension than white patients with probable AD, and whites had higher rates of atrial fibrillation and cancer. This finding suggests that these comorbid illnesses in black and white patients with probable AD is not due to a statistical Type II error, but rather to differences in these groups.

Entities:  

Mesh:

Year:  2004        PMID: 14746413     DOI: 10.1097/01.SMJ.0000077061.01235.42

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Race and cognitive decline among community-dwelling elders with mild cognitive impairment: findings from the Memory and Medical Care Study.

Authors:  Hochang B Lee; Amanda K Richardson; Betty S Black; Andrew D Shore; Judith D Kasper; Peter V Rabins
Journal:  Aging Ment Health       Date:  2011-10-14       Impact factor: 3.658

2.  Disparities in Alzheimer Disease and Mild Cognitive Impairment Among Native Hawaiians and Pacific Islanders.

Authors:  Maiya Smith; Nicholas Van; Alyssa Roberts; Kalei R J Hosaka; So Yung Choi; Jason Viereck; Enrique Carrazana; Pat Borman; John J Chen; Kore Kai Liow
Journal:  Cogn Behav Neurol       Date:  2021-09-02       Impact factor: 1.590

Review 3.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Co-morditities of environmental diseases: A common cause.

Authors:  Harold I Zeliger
Journal:  Interdiscip Toxicol       Date:  2014-12-30

Review 5.  Comorbidity and dementia: a scoping review of the literature.

Authors:  Frances Bunn; Anne-Marie Burn; Claire Goodman; Greta Rait; Sam Norton; Louise Robinson; Johan Schoeman; Carol Brayne
Journal:  BMC Med       Date:  2014-10-31       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.